Radiotherapy, immunity, and immune checkpoint inhibitors

• Published in: The lancet oncology Vol. 25; no. 8; pp. e352 - e362
• Main Authors: Lynch, Connor, Pitroda, Sean P, Weichselbaum, Ralph R
• Format: Journal Article
• Language: English
• Published: London Elsevier Ltd 01.08.2024; Elsevier Limited
• Subjects: Adenosine; Antigen presentation; Cell death; Clinical trials; Cytotoxicity; Dendritic cells; Immune checkpoint inhibitors; Immune response; Immune system; Immunity (Disease); Immunostimulation; Immunosuppression; Immunotherapy; Interferon; Lung cancer; Lymphocytes; Metastases; Metastasis; Radiation therapy; Signal transduction; Tumor microenvironment; Tumors
• ISSN: 1470-2045; 1474-5488; 1474-5488
• DOI: 10.1016/S1470-2045(24)00075-5

Radiotherapy exerts immunostimulatory and immunosuppressive effects, both locally, within the irradiated tumour microenvironment, and systemically, outside the radiation field. Inspired by preclinical data that showed synergy between radiotherapy and immune checkpoint inhibitors, multiple clinical trials were initiated with the hypothesis that combined treatment with radiotherapy and immune checkpoint inhibitors could stimulate a robust systemic immune response and improve clinical outcomes. However, despite early optimism, radioimmunotherapy trials in the curative and metastatic settings have met with little success. In this Review, we summarise the immunostimulatory effects of radiotherapy that provided the theoretical basis for trials of combination radiotherapy and immune checkpoint inhibitors. We also discuss findings from clinical trials incorporating radiotherapy and immune checkpoint inhibitors and examine the success of these trials in the context of the immunosuppressive effects of radiotherapy. We conclude by highlighting targets for relieving radiotherapy-induced immunosuppression with the goal of enhancing the combined effects of radiotherapy and immune checkpoint inhibitors.